VIR logo Vir Biotechnology : VIR

VIR

Stock Data

$9.16

Change down

$0.14 (1.51%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Vir Biotechnology Inc is a pioneering immunology company focused on developing treatments for serious infectious diseases. With a robust pipeline, it targets conditions like chronic hepatitis, HIV, respiratory viruses, influenza, HPV lesions, and COVID-19. The company collaborates with notable organizations and companies, including the Bill & Melinda Gates Foundation, National Institutes of Health, and GlaxoSmithKline, to advance its research and development efforts. Founded in 2016 and based in San Francisco, Vir Biotechnology leverages partnerships and cutting-edge science to create solutions for global health challenges.

All Vir Biotechnology Articles

11 Articles